Connect with us

Health

The Covid-19 vaccine rollout: which emerging economies are leading the way?

While many rich nations have been able to produce or purchase sufficient doses to inoculate their populations several times over, some less developed countries are struggling to guarantee supplies

Oxford Business Group

Published

on

A growing number of countries around the world are launching Covid-19 vaccine programmes, generating optimism that there is a light at the end of the pandemic tunnel.

Loading...

However, while some developing economies are successfully moving forwards with their own programmes, others have expressed concern about an emerging global imbalance in distribution.

Governments around the world spent €93bn on Covid-19 vaccines and therapeutics in 2020, around €86.5bn of which went to vaccine producers, according to the kENUP Foundation, a non-profit organisation.

Of this total, 32% came from the US, 24% from the EU, and a total of 13% from Japan and South Korea. Thanks in part to such investment, the UK, the US, China, India and Russia have all developed clinically approved Covid-19 vaccines. As a result of national and multinational initiatives, approximately 39m doses had been administered in 49 countries as of January 19. 

While many rich nations have been able to produce or purchase sufficient doses to inoculate their populations several times over, some less developed countries are struggling to guarantee supplies. Tedros Adhanom Ghebreyesus, the director-general of the World Health Organisation (WHO), has warned that an uneven distribution of vaccines risks prolonging the pandemic.

Further to questions of supply, it is feared that some middle- and lower-income countries will have to overcome logistics-related hurdles to provide vaccines to all citizens. Vaccines are biological products that can be damaged by different environmental conditions, such as very high or low temperatures, or excessive light.

It is thus essential that they are transported and stored appropriately. For example, the Pfizer-BioNTech vaccine must be kept refrigerated at -70°C, meaning that its distribution requires considerable cold-chain logistics capacity, which is both expensive and dependent on an efficient road network.  Another challenge is related to logistics and ICT. Successfully inoculating the entire population of a given country requires a comprehensive, up-to-date and reliable database – something not all nations possess.

Excerpt from:

The Covid-19 vaccine rollout: which emerging economies are leading the way? | Oxford Business Group

With some of the industry’s most experienced analysts conducting on-the-ground research throughout the year, OBG provides its global readership with the business intelligence they need to stay ahead.

Comments

Health

Skin-lightening products market to reach US$31 billion by 2024

In emerging Asian and African economies, the natural aspiration to enhance one’s circumstances has led to rapid growth in the market for skin-lightening products, which is projected to reach US$31 billion by 2024.

Avatar

Published

on

Recent years have seen evolving awareness of systemic inequities including racism, sexism and pro-Western chauvinism.

Loading...
(more…)

Continue Reading

Ecommerce

Has Covid-19 prompted the Belt and Road Initiative to go green?

Oxford Business Group

Published

on

Has Covid-19 prompted the Belt and Road Initiative to go green?
– Covid-19 led to a slowdown in BRI projects
– Chinese overseas investment dropped off in 2020
– Government remains committed to the wide-ranging infrastructure programme
– Sustainability, health and digital to be the new cornerstones of the initiative 

Loading...

Following a year of coronavirus-related disruptions, China appears to be placing a greater focus on sustainable, digital and health-related projects in its flagship Belt and Road Initiative (BRI).

As OBG outlined in April last year, the onset of Covid-19 prompted questions about the future direction of the BRI.

Launched in 2013, the BRI is an ambitious international initiative that aims to revive ancient Silk Road trade routes through large-scale infrastructure development.

By the start of 2020 some 2951 BRI-linked projects – valued at a total of $3.9trn – were planned or under way across the world.

However, as borders closed and lockdowns were imposed, progress stalled on a number of major BRI infrastructure developments.

In June China’s Ministry of Foreign Affairs announced that 30-40% of BRI projects had been affected by the virus, while a further 20% had been “seriously affected”. Restrictions on the flow of Chinese workers and construction supplies were cited as factors behind project suspensions or slowdowns in Pakistan, Cambodia and Indonesia, among other countries.

Read More

Continue Reading

Business

Marijuana could generate up to Bt8 billion for Thailand’s pharmaceutical industry

Last year, Thailand removed cannabis and hemp leaves from its list of banned narcotics (seeds and buds remain banned).

Avatar

Published

on

Marijuana could generate up to Bt8 billion for Thailand’s pharmaceutical industry over the next five years, but farmers stand to make little from growing the herb, experts say.

Loading...
(more…)

Continue Reading

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,634 other subscribers

Trending